104 related articles for article (PubMed ID: 9686771)
21. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
Kotake Y; Taguchi R; Okuda K; Sekiya Y; Tasaki Y; Hirobe M; Ohta S
Brain Res; 2005 Feb; 1033(2):143-50. PubMed ID: 15694918
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
[TBL] [Abstract][Full Text] [Related]
24. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
[TBL] [Abstract][Full Text] [Related]
26. Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death.
Fernandez-Gomez FJ; Gomez-Lazaro M; Pastor D; Calvo S; Aguirre N; Galindo MF; Jordán J
Neurobiol Dis; 2005 Nov; 20(2):384-91. PubMed ID: 16242643
[TBL] [Abstract][Full Text] [Related]
27. Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity.
Filiz G; Caragounis A; Bica L; Du T; Masters CL; Crouch PJ; White AR
Int J Biochem Cell Biol; 2008; 40(5):1030-42. PubMed ID: 18160328
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
29. The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators.
Youdim MB; Grünblatt E; Mandel S
Ann N Y Acad Sci; 1999; 890():7-25. PubMed ID: 10668410
[TBL] [Abstract][Full Text] [Related]
30. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism.
Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z
Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341
[TBL] [Abstract][Full Text] [Related]
31. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
Mazzio EA; Reams RR; Soliman KF
Brain Res; 2004 Apr; 1004(1-2):29-44. PubMed ID: 15033417
[TBL] [Abstract][Full Text] [Related]
32. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
Baluchnejadmojarad T; Roghani M; Mafakheri M
Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action.
Zhu TG; Wang XX; Luo WF; Zhang QL; Huang TT; Xu XS; Liu CF
Neurosci Lett; 2012 Jan; 506(2):175-9. PubMed ID: 22094380
[TBL] [Abstract][Full Text] [Related]
35. Apomorphine attenuates 6-hydroxydopamine-induced apoptotic cell death in SH-SY5Y cells.
Hara H; Ohta M; Ohta K; Kuno S; Adachi T
Redox Rep; 2003; 8(4):193-7. PubMed ID: 14599342
[TBL] [Abstract][Full Text] [Related]
36. Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine.
Youdim MB; Gassen M; Gross A; Mandel S; Grünblatt E
J Neural Transm Suppl; 2000; (58):83-96. PubMed ID: 11128615
[TBL] [Abstract][Full Text] [Related]
37. Protection of dopaminergic neurons in primary culture by lisuride.
Gille G; Rausch WD; Hung ST; Moldzio R; Ngyuen A; Janetzky B; Engfer A; Reichmann H
J Neural Transm (Vienna); 2002 Feb; 109(2):157-69. PubMed ID: 12075855
[TBL] [Abstract][Full Text] [Related]
38. COA-Cl Evokes Protective Responses Against H
Jamal M; Tsukamoto I; Maki T; Takei S; Konishi R; Kinoshita H
Neurotox Res; 2022 Dec; 40(6):2061-2071. PubMed ID: 36435924
[TBL] [Abstract][Full Text] [Related]
39. Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury.
Song L; Song W; Schipper HM
J Neurosci Res; 2007 Aug; 85(10):2186-95. PubMed ID: 17526019
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA)-induced toxicity in PC12 cells.
Magalingam KB; Radhakrishnan A; Haleagrahara N
BMC Res Notes; 2014 Jan; 7():49. PubMed ID: 24443837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
